心房颤动合并衰弱的研究进展  

Progress in the study of atrial fibrillation combined with frailty

作　　者：王雅婧 张晋豫 何海龙(综述) 谢连娣(审校)[3] Wang Yajing;Zhang Jinyu;He Hailong;Xie Liandi(Department of Cardiology,Oriental Hospital,Postgraduate School of Beijing University of Chinese Medicine,Beijing 100029,China;不详)

机构地区：[1]北京中医药大学研究生院,北京100029 [2]北京中医药大学针灸推拿学院 [3]北京中医药大学东方医院心血管内科,北京100078

出　　处：《疑难病杂志》2025年第2期239-242,252,共5页Chinese Journal of Difficult and Complicated Cases

基　　金：国家中医药管理局第五批全国中医临床优秀人才研修项目(国中医药人教函〔2022〕1号)。

摘　　要：心房颤动与衰弱的发病率均会随着年龄的增加而增长,常同时发生。心房颤动合并衰弱的发病率报道不一,可能取决于评估衰弱的工具不同。二者关系密切,衰弱会加重心房颤动不良预后的风险,心房颤动亦会增加衰弱的可能性。衰弱会影响心房颤动的治疗方案,它可能会减少心房颤动的抗凝治疗,但有关衰弱对抗心律失常治疗及射频消融等手术治疗的影响证据较少。因此,临床对心房颤动制定个体化治疗方案时,推荐进行衰弱评估。文章就心房颤动合并衰弱的相关研究进展作一综述。The prevalence of both atrial fibrillation(AF)and debility increases with physiological age and often occurs simultaneously.The reported prevalence of AF combined with debility is variable and may depend on different tools used to assess debility.The two are closely related,with debility increasing the risk of poor prognosis in AF and AF increasing the likelihood of debility.Frailty has an impact on treatment options for AF,and it may reduce anticoagulation for AF,but there is less evidence about the impact of frailty on antiarrhythmic therapy and surgical treatments such as radiofrequency ablation.Therefore,debilitation assessment is recommended when developing an individualized treatment plan for AF in the clinic.

关 键 词：心房颤动 衰弱 预后 治疗 

分 类 号：R541.75[医药卫生—心血管疾病]